← Leaderboards
Lorenzo Leggio
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
Others in their field
Top investigators on “Substance Use Disorder”
- Jeffrey H Samet · Boston University Medical Campus$89,407,012
- Randall J Bateman · Washington University$84,370,732
- David Heimbrook · Leidos Biomedical Research, Inc.$68,229,403
- Edward V Nunes · Columbia University Health Sciences$52,813,531
- Roger D. Weiss · Mc Lean Hospital (Belmont, Ma)$47,777,646
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
Substance Use DisorderAddictionClinical ResearchPharmaceutical PreparationsSafetyUnited States National Institutes Of HealthNational Institute Of Drug AbuseInvestigationLaboratoriesRecruitAlcohol Use DisorderAlcoholsAlcohol ConsumptionPersonsMedicineInnovationNational Institute On Alcohol Abuse And AlcoholismProceduresOutpatientsMaleIntramural Research ProgramPharmacotherapyInpatientsArea
Grant awards (19)
Office of the Clinical Director$13,263,662
ZID · FY2025 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,696,667
ZIA · FY2025 · DA · contact PI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program$1,759,733
ZID · FY2025 · DA · contact PI
Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.$424,251
ZIA · FY2025 · DA · contact PI
Office of the Clinical Director$7,699,121
ZID · FY2024 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,465,296
ZIA · FY2024 · DA · contact PI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program$1,683,955
ZID · FY2024 · DA · contact PI
Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.$405,983
ZIA · FY2024 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,972,035
ZIA · FY2023 · DA · contact PI
Office of the Clinical Director$1,779,088
ZID · FY2023 · DA · contact PI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program$1,611,440
ZID · FY2023 · DA · contact PI
Investigating the effects of novel medications for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV.$388,500
ZIA · FY2023 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,535,440
ZIA · FY2022 · DA · contact PI
NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program$1,642,936
ZID · FY2022 · DA · contact PI
Office of the Clinical Director$517,666
ZID · FY2022 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,201,443
ZIA · FY2021 · DA · contact PI
Translational Addiction Medicine$244,605
ZIA · FY2021 · DA · contact PI
Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)$2,346,019
ZIA · FY2020 · DA · contact PI
Translational Addiction Medicine$260,669
ZIA · FY2020 · DA · contact PI